Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 110 results found. Search for [ india COVID-19 vaccine grant ]

Results 60 to 80 of 110
BusinessToday.In
January 4, 2021
Defending Covaxin, the Bhart Biotech Chairman said that his company has tremendous experience in developing vaccines; more than 70 articles on data related to Covaxin have been published in various journals


BusinessToday.In
January 3, 2021
COVID-19 vaccines in India: Oxford-AstraZeneca's coronavirus vaccine Covishield and Bharat Biotech's COVID vaccine Covaxin will be India's first vaccines


BusinessToday.In
January 2, 2021
IIM-Sambalpur foundation stone laying ceremony today:The IIM-Sambalpur virtual foundation stone laying ceremony will be attended by around 5,000 invitees


BusinessToday.In
December 31, 2020
The ministry has also said that programme managers and implementers must plan to prevent and minimise preventable Adverse Events Following Immunisation (AEFIs)


BusinessToday.In
December 30, 2020
This development comes hours after the UK government accepted the recommendation from the Medicines and Healthcare Regulatory Agency (MHRA) to authorise Oxford University-AstraZeneca's Covid-19 vaccine, named Covishield, for emergency use


BusinessToday.In
December 29, 2020
The chief executive of Serum Institute - the biggest vaccine maker in the world by volume - said all trial data for Covishield has been provided to authorities in the UK and India as \"nobody wants to risk safety\"


PTI
December 27, 2020
Serum Institute of India (SII) has made a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine. The SII has already manufactured 40 million doses of the vaccine


BusinessToday.In
December 19, 2020
The COVID-19 vaccine in India will be first offered to healthcare workers, frontline workers and persons above 50 years of age. Depending on the disease epidemiology and vaccine's availability, the remaining population will be vaccinated later on


PTI
December 16, 2020
The applications are being examined on scientific basis, using the frameworks that are scientific, frameworks that are globally aligned and ensuring that the vaccine is safe, NITI Aayog member (health) Dr V K Paul said


BusinessToday.In
December 11, 2020
The mRNA vaccine candidate -  HGCO19 - is being developed by Pune-based company Gennova, and is supported with seed grant under the Ind-CEPI mission of Department of Biotechnology under Ministry of Science and Technology


BusinessToday.In
December 11, 2020
The regulatory approval in the UK is crucial to strengthen SII's application seeking emergency use authorisation in India because the proposal here refers to trials being conducted in the UK and Brazil


BusinessToday.In
December 10, 2020
The Subject Expert Committee (SEC), a government panel tasked with vetting coronavirus vaccines, has asked Bharat Biotech and Serum Institute of India (SII) to submit updated country-specific trial data of their vaccine candidates Covaxin and Covishield


PTI
December 8, 2020
Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation


BusinessToday.In
December 7, 2020
As per the Indian Council of Medical Research (ICMR), Serum Institute has manufactured four crore doses of the vaccine under the at-risk manufacturing and stockpiling licence obtained from the DCGI


Reuters
December 2, 2020
The move to grant emergency authorisation to the Pfizer/BioNTech vaccine has been seen by many as a political coup for UK Prime Minister Boris Johnson, who has led his country out of the EU


BusinessToday.In
November 27, 2020
After the publication of early data from phase-3 clinical trials, drugmakers Pfizer and BioNTech have sought regulatory approval to deploy their inoculation under emergency-use rules. American biotech company Moderna is also likely to do the same soon


PTI
November 27, 2020
The mission envisages Covid-19 vaccine development with end-to-end focus from preclinical through clinical development and manufacturing and regulatory facilitation, the DBT said


Nevin John
November 24, 2020
Niranjan Hiranandani, founder and managing director, Hiranandani Group, told Business Today that a large section of homebuyers in metro cities are helping the revival of sales


PTI
November 24, 2020
The probity watchdog expressed deep concerns over prolonged delay in filing of such details by the government officials and set the November 30 deadline for 100 per cent compliance


BusinessToday.In
November 24, 2020
Advertisement created a stir because COVID-19 vaccine is yet to be rolled out for masses, and Centre is working on a distribution system once vaccine is available


PAGES 4 OF 6  12345